Healthcare Selling And Marketing Expenses from 2010 to 2024

HCSG Stock  USD 12.38  0.25  2.06%   
Healthcare Services' Selling And Marketing Expenses is increasing over the last several years with slightly volatile swings. Selling And Marketing Expenses is estimated to finish at about 11.1 M this year. During the period from 2010 to 2024 Healthcare Services Group Selling And Marketing Expenses regressed destribution of quarterly values had coefficient of variationof  81.90 and r-value of  0.86. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2012-03-31
Previous Quarter
1.2 M
Current Value
39.4 M
Quarterly Volatility
8.8 M
 
Yuan Drop
 
Covid
Check Healthcare Services financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare Services' main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.1 M, Interest Expense of 8.2 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.9, Dividend Yield of 0.0671 or PTB Ratio of 2.84. Healthcare financial statements analysis is a perfect complement when working with Healthcare Services Valuation or Volatility modules.
  
Check out the analysis of Healthcare Services Correlation against competitors.

Latest Healthcare Services' Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of Healthcare Services Group over the last few years. It is Healthcare Services' Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthcare Services' overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

Healthcare Selling And Marketing Expenses Regression Statistics

Arithmetic Mean4,731,609
Geometric Mean2,815,007
Coefficient Of Variation81.90
Mean Deviation3,420,597
Median3,005,000
Standard Deviation3,874,980
Sample Variance15T
Range11M
R-Value0.86
Mean Square Error4.2T
R-Squared0.74
Significance0.000036
Slope746,708
Total Sum of Squares210.2T

Healthcare Selling And Marketing Expenses History

202411.1 M
202310.6 M
20229.2 M
20216.7 M
20209.2 M
20197.4 M
20181.5 M

About Healthcare Services Financial Statements

Healthcare Services stakeholders use historical fundamental indicators, such as Healthcare Services' Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although Healthcare Services investors may analyze each financial statement separately, they are all interrelated. For example, changes in Healthcare Services' assets and liabilities are reflected in the revenues and expenses on Healthcare Services' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Healthcare Services Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling And Marketing Expenses10.6 M11.1 M

Currently Active Assets on Macroaxis

When determining whether Healthcare Services is a strong investment it is important to analyze Healthcare Services' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Healthcare Services' future performance. For an informed investment choice regarding Healthcare Stock, refer to the following important reports:
Check out the analysis of Healthcare Services Correlation against competitors.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Commercial Services & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Services. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Services listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.322
Earnings Share
0.69
Revenue Per Share
23.052
Quarterly Revenue Growth
0.041
Return On Assets
0.048
The market value of Healthcare Services is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Services' value that differs from its market value or its book value, called intrinsic value, which is Healthcare Services' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Services' market value can be influenced by many factors that don't directly affect Healthcare Services' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Services' value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Services is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Services' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.